City of Hope is one of the top ten cancer research and treatment organizations in the United States. Moreover, it’s a leading research institution for diabetes as well as other life-threatening illnesses. Recently, they announced the return of their #GivingisBeautiful campaign. A community of the most socially driven and influential brands, retailers, ambassadors, and individuals all striving to create a lasting change through the common goal of eradicating cancer.
Created by beauty industry leaders during the pandemic and now in its second year, the campaign featuring brands including L’Oreal Professional Products who are matching donations dollar for dollar up to $25,000, and sponsors like Revitalash, Moss Adams and Sephora has officially begun. Launched on #GivingTuesday, and culminating on World Cancer Day, February 4, 2023 the campaign harnesses the strength of the collective to power cancer innovation globally.
After raising just shy of half a million dollars in its inaugural year, and partnership from industry influencers like @jamielvandenberg, @thejesjewel and @krystalclearmakeup, this year the campaign will further expand to lifestyle industries including fashion and retail, health and wellness, design and furniture, film and entertainment, and more to accelerate breakthroughs that have improved treatments, outcomes and, quite simply, saved lives. Now WE NEED YOU.
To learn more about the campaign visit HERE.
About City of Hope
City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute-designated comprehensive cancer center, City of Hope brings a uniquely integrated model to patients, spanning cancer care, research and development, academics and training, and innovation initiatives. Research and technology developed at City of Hope has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. A leader in bone marrow transplantation and immunotherapy, such as CAR T cell therapy, City of Hope’s personalized treatment protocols help advance cancer care throughout the world.
With a goal of expanding access to the latest discoveries and leading-edge care to more patients, families and communities, City of Hope’s growing national system includes its main Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and Cancer Treatment Centers of America. City of Hope’s affiliated family of organizations includes Translational Genomics Research Institute and AccessHope. For more information about City of Hope, follow them on Facebook, Twitter, YouTube, Instagram and LinkedIn.
